Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo
- PMID: 1362807
- DOI: 10.1016/0304-3940(92)90597-z
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo
Abstract
When applied locally to the caudate nucleus of the halothane-anaesthetized cat, riluzole (10(-5) M) markedly reduced (-57%) the spontaneous release of glutamate. This effect seems to be specific, since the efflux of the other amino acids, including aspartate was not affected. Indicating further its selective inhibitory effect on the spontaneous release of glutamate, the prolonged (90 min) application of riluzole (10(-5) M) enhanced the size of the potassium-releasable pool of glutamate, but not that of aspartate. This effect of riluzole was not noticed with classical anti-glutamatergic drugs, tested in the same conditions.
Similar articles
-
In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: involvement of GABA neurons.Brain Res. 1990 Jun 11;519(1-2):82-8. doi: 10.1016/0006-8993(90)90063-h. Brain Res. 1990. PMID: 1975768
-
In vivo presynaptic control of dopamine release in the cat caudate nucleus--II. Facilitatory or inhibitory influence of L-glutamate.Neuroscience. 1986 Dec;19(4):1081-90. doi: 10.1016/0306-4522(86)90124-7. Neuroscience. 1986. PMID: 2881227
-
The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1.Eur J Pharmacol. 1993 Dec 21;250(3):473-6. doi: 10.1016/0014-2999(93)90037-i. Eur J Pharmacol. 1993. PMID: 8112408
-
Activation of the bilateral corticostriatal glutamatergic projection by infusion of GABA into thalamic motor nuclei in the cat: an in vivo release study.Neuroscience. 1989;28(2):365-74. doi: 10.1016/0306-4522(89)90183-8. Neuroscience. 1989. PMID: 2564170
-
Effect of reserpine on the turnover of glutamate, glutamine, aspartate and GABA labeled with [1-14C]acetate in caudate nucleus, thalamus and sensorimotor cortex(cat).Brain Res. 1969 Aug;14(3):683-95. doi: 10.1016/0006-8993(69)90208-x. Brain Res. 1969. PMID: 5822438 No abstract available.
Cited by
-
Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells.Oncotarget. 2017 Jul 4;8(27):44639-44653. doi: 10.18632/oncotarget.17961. Oncotarget. 2017. PMID: 28591718 Free PMC article.
-
Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity.J Neurosci. 2002 Sep 15;22(18):8312-23. doi: 10.1523/JNEUROSCI.22-18-08312.2002. J Neurosci. 2002. PMID: 12223586 Free PMC article.
-
The fraction of activated N-methyl-D-aspartate receptors during synaptic transmission remains constant in the presence of the glutamate release inhibitor riluzole.J Neural Transm (Vienna). 2008 Aug;115(8):1119-26. doi: 10.1007/s00702-008-0059-y. Epub 2008 May 21. J Neural Transm (Vienna). 2008. PMID: 18493706 Free PMC article.
-
A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?CNS Neurosci Ther. 2011 Feb;17(1):4-31. doi: 10.1111/j.1755-5949.2009.00116.x. CNS Neurosci Ther. 2011. PMID: 20236142 Free PMC article.
-
Riluzole in the treatment of mood and anxiety disorders.CNS Drugs. 2008;22(9):761-86. doi: 10.2165/00023210-200822090-00004. CNS Drugs. 2008. PMID: 18698875 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous